Details of issuance or disposal
Changes to the use of proceeds from the issuance of new shares through a third-party allotment and the issuance of the 3rd Series of Stock Acquisition Rights (with exercise price adjustment provisions)
¥100 million raised through the issuance of new shares in the previous financing, ¥250 million of the funds to be raised through new financing, and estimated net proceeds of Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Changes to the use of proceeds from the issuance of new shares through a third-party allotment and the issuance of the 3rd Series of Stock Acquisition Rights (with exercise price adjustment provisions) |
| Amount of funds to be raised | ¥100 million raised through the issuance of new shares in the previous financing, ¥250 million of the funds to be raised through new financing, and estimated net proceeds of Not disclosed |
| Specific use of funds | Details Acquisition of a columbarium business / Amount ¥100 million / Scheduled timing of expenditures May-July 2026, Details Funds for the subscription for a capital increase associated with the capital and business alliance with itowa Co., Ltd. / Amount ¥50 million / Scheduled timing of expenditures May-July 2025 |
| Exercise price | The 3rd Series of Stock Acquisition Rights have exercise price adjustment provisions. The floor for the adjustment is Not disclosed |
| Number of Stock Acquisition Rights | All remaining 3rd Series of Stock Acquisition Rights will be acquired and cancelled as of 7 May 2026. The total number issued is Not disclosed |
| Reason for acquisition without consideration | Acquisition pursuant to the grounds for acquisition stipulated in the terms and conditions of the 3rd Series of Stock Acquisition Rights |
| Most recent equity financing | Timing Announced on 15 April 2025 / Type Issuance of new shares through a third-party allotment and issuance of the Third Stock Acquisition Rights (with Exercise Price Adjustment Clause) / Amount ¥100 million raised through the issuance of new shares; total use of proceeds of ¥150 million |
| Impact on Business Performance | The impact on results for the fiscal year ending March 2026 from the change in the planned expenditure period is expected to be immaterial. |
Items this document does not state (20)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The 3rd Series of Stock Acquisition Rights were not exercised as anticipated due to factors including market conditions, preventing the Company from raising the initially expected funds in a timely manner. Subsequently, the Company came to expect that it would be able to carry out the business acquisition through new financing.